Cargando…

Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson’s Disease

(123)I-ioflupane SPECT (DaTscan) is an examination that detects presynaptic dopamine neuronal dysfunction, and has been used as a diagnostic tool to identify degenerative parkinsonism. Additionally, myocardial (123)I-metaiodobenzyl guanidine (MIBG) scintigraphy measures the concentration of cardiac...

Descripción completa

Detalles Bibliográficos
Autores principales:	ASAHI, Takashi, KASHIWAZAKI, Daina, YONEYAMA, Tatsuya, NOGUCHI, Kyo, KURODA, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japan Neurosurgical Society 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791306/ https://www.ncbi.nlm.nih.gov/pubmed/26794041 http://dx.doi.org/10.2176/nmc.oa.2015-0234

Ejemplares similares

(123)I-ioflupane brain SPECT and (123)I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders
por: Nuvoli, Susanna, et al.
Publicado: (2017)

Reduced 123I Ioflupane Binding in Bilateral Diabetic Chorea: Findings With 18F FDG PET, 99mTc ECD SPECT, and 123I MIBG Scintigraphy
por: Sato, Kenichiro, et al.
Publicado: (2016)

Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses
por: Badoud, Simon, et al.
Publicado: (2016)

CT-Based Attenuation Correction in I-123-Ioflupane SPECT
por: Lange, Catharina, et al.
Publicado: (2014)

Diagnosis of dementia with Lewy bodies: diagnostic performance of combined (123)I-IMP brain perfusion SPECT and (123)I-MIBG myocardial scintigraphy
por: Sakamoto, Fumi, et al.
Publicado: (2013)

Bipolar Disorder and Parkinson's Disease: A (123)I-Ioflupane Dopamine Transporter SPECT Study
por: Erro, Roberto, et al.
Publicado: (2021)

Potential Utility of (123)I-MIBG Scintigraphy as a Predictor of Falls in Parkinson's Disease
por: Murakami, Nagahisa, et al.
Publicado: (2019)

Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review
por: Pitton Rissardo, Jamir, et al.
Publicado: (2023)

Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease
por: Spiegel, Jörg
Publicado: (2009)

The utility of the combination of a SPECT study with [(123)I]-FP-CIT of dopamine transporters and [(123)I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes
por: Uyama, Naoto, et al.
Publicado: (2017)

Cardiac 123I-MIBG Scintigraphy in Neurodegenerative Parkinson Syndromes: Performance and Pitfalls in Clinical Practice
por: Skowronek, Cornelia, et al.
Publicado: (2019)

Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure
por: Veltman, Caroline E., et al.
Publicado: (2012)

Robust Ensemble Classification Methodology for I123-Ioflupane SPECT Images and Multiple Heterogeneous Biomarkers in the Diagnosis of Parkinson's Disease
por: Castillo-Barnes, Diego, et al.
Publicado: (2018)

Myocardial (123)I-MIBG Uptake and Cardiovascular Autonomic Function in Parkinson's Disease
por: Katagiri, Akira, et al.
Publicado: (2015)

Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson’s disease
por: Boccalini, Cecilia, et al.
Publicado: (2022)

Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease
por: Shimizu, Soichiro, et al.
Publicado: (2015)

Erratum: Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson's disease
Publicado: (2023)

123I‐MIBG scintigraphy and 18F‐FDG‐PET imaging for diagnosing neuroblastoma
por: Bleeker, Gitta, et al.
Publicado: (2015)

Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ((123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout
por: Verberne, Hein J., et al.
Publicado: (2009)

Accumulation of (123)I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson’s Disease
por: Murakami, Hidetomo, et al.
Publicado: (2017)

The role of (123)I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies
por: Antonini, Angelo
Publicado: (2007)

Impact of the cerebrospinal fluid-mask algorithm on the diagnostic performance of (123)I-Ioflupane SPECT: an investigation of parkinsonian syndromes
por: Iwabuchi, Yu, et al.
Publicado: (2019)

Diagnostic Effectiveness of [(123)I]Ioflupane Single Photon Emission Computed Tomography (SPECT) in Multiple System Atrophy
por: Villena-Salinas, Javier, et al.
Publicado: (2023)

Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of (123)I-Ioflupane SPECT in Assessing Clinical Symptoms of Drug-Naïve Parkinson’s Disease Patients
por: Murakami, Hidetomo, et al.
Publicado: (2018)

Renal Function in Relation to Cardiac (123)I-MIBG Scintigraphy in Patients with Chronic Heart Failure
por: Verschure, Derk O., et al.
Publicado: (2012)

Vascular time-activity variation in patients undergoing (123)I-MIBG myocardial scintigraphy: implications for quantification of cardiac and mediastinal uptake
por: Verberne, Hein J., et al.
Publicado: (2011)

Elevated Heart Rate is Associated with Cardiac Denervation in Patients with Heart Failure: A 123-Iodine-MIBG Myocardial Scintigraphy Study
por: Villacorta, Aline Sterque, et al.
Publicado: (2016)

Dynamic planar scintigraphy for the rapid kinetic measurement of myocardial (123)I-MIBG turnover can identify Lewy body disease
por: Kumakura, Yoshitaka, et al.
Publicado: (2021)

(123)I‐Metaiodobenzylguanidine Myocardial Scintigraphy in Discriminating Degenerative Parkinsonisms
por: Catalan, Mauro, et al.
Publicado: (2021)

Analysis of quantitative [I-123] mIBG SPECT/CT in a phantom and in patients with neuroblastoma
por: Brady, Samuel L., et al.
Publicado: (2019)

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2013)

Clinical Comparison of (99m)Tc Exametazime and (123)I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain Injury
por: Newberg, Andrew B., et al.
Publicado: (2014)

Comparison between Different Intensity Normalization Methods in (123)I-Ioflupane Imaging for the Automatic Detection of Parkinsonism
por: Brahim, A., et al.
Publicado: (2015)

Transformation of a nonfunctional paraganglioma with I-123 MIBG scintigraphy correlation: A case report: Notice of Retraction
Publicado: (2016)

Bilateral adrenal uptake of (123)I MIBG scintigraphy with mild catecholamine elevation, the diagnostic dilemma, and its characteristics
por: Inaba, Yuiko, et al.
Publicado: (2022)

Myocardial (123)I-mIBG scintigraphy in relation to markers of inflammation and long-term clinical outcome in patients with stable chronic heart failure
por: Verschure, Derk O., et al.
Publicado: (2016)

Assessment of global cardiac I-123 MIBG uptake and washout using volumetric quantification of SPECT acquisitions
por: van der Veen, Berlinda J., et al.
Publicado: (2012)

Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy
por: Brumberg, Joachim, et al.
Publicado: (2020)

Correction: Comparison between Different Intensity Normalization Methods in (123)I-Ioflupane Imaging for the Automatic Detection of Parkinsonism
por: Brahim, A., et al.
Publicado: (2015)

Polymorphism of SLC6A2 gene does not influence outcome of myocardial (123)I-mIBG scintigraphy in patients with chronic heart failure
por: Verschure, Derk O., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0b3pep1v2h90p2ud2a6fmb2erf